No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AU Stock MarketDetailed Quotes
MYX Mayne Pharma Group Ltd
- 4.470
- +0.040+0.90%
20min DelayNot Open Jan 16 16:00 AET
363.17MMarket Cap-2.04P/E (Static)
4.530High4.410Low64.38KVolume4.430Open4.430Pre Close286.84KTurnover7.46052wk High0.11%Turnover Ratio81.25MShares3.74052wk Low-2.19EPS TTM272.12MFloat Cap31.320Historical HighLossP/E (Static)60.88MShs Float-10.006Historical Low-2.19EPS LYR2.71%Amplitude--Dividend TTM0.80P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Mayne Pharma: Settlement Dismisses Claims Without Admission of Liability
Mayne Pharma Confirms Financial Adviser Appointment for Strategic Review
Shareholders in Mayne Pharma Group (ASX:MYX) Are in the Red If They Invested Five Years Ago
Mayne Pharma Target Price Cut 16% to A$5.93/Share by Wilsons>MYX.AU
Mayne Pharma Price Target Cut 6.6% to A$6.25/Share by Canaccord Genuity
Why Bank of Queensland, Fisher & Paykel, Mayne Pharma, and Medibank Shares Are Rising
Trending AU Stocks
ASX High Dividend ASX High Dividend